We are live on
!
Find out more
WC
Weil Company Portfolio holdings
AUM
$445M
1-Year Est. Return
14.95%
This Fund
S&P 500
This Quarter
Est. Return
+10.96%
1 Year Est. Return
+14.95%
3 Year Est. Return
+51.9%
5 Year Est. Return
+85.1%
10 Year Est. Return
–
AUM
$228M
AUM Growth
+$26.5M
(+13%)
Cap. Flow
+$5.22M
Cap. Flow
% of AUM
2.29%
Top 10 Holdings %
Top 10 Hldgs %
41.39%
Holding
148
New
16
Increased
45
Reduced
38
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Global Clean Energy ETF
ICLN
|
+$4.74M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.49M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$3.44M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$3.43M |
| 5 |
TCW Transform Supply Chain ETF
SUPP
|
+$3.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$6.36M |
| 2 |
Criteo
CRTO
|
+$2.29M |
| 3 |
Box
BOX
|
+$2.01M |
| 4 |
Valmont Industries
VMI
|
+$1.99M |
| 5 |
Fortinet
FTNT
|
+$1.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.1% |
| 2 | Financials | 14.04% |
| 3 | Real Estate | 8.73% |
| 4 | Industrials | 6.92% |
| 5 | Healthcare | 5.34% |
Similar funds
RWM
NAMP
BI
MLIC
JDLA
AFA
SGCM
WCP
Weil Company's Q4 2023 Portfolio in Review
As of Q4 2023, Weil Company held 148 positions worth $228M, up 13% from $201M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Weil Company's Q4 2023 filing shows 16 new, 45 increased, 38 reduced and 13 closed positions. Its largest new stake was iShares Global Clean Energy ETF: 337,097 shares worth $5.25M. The largest sale was United Therapeutics, an estimated $6.36M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Financials and Real Estate.
- Weil Company's largest Q4 2023 buy was iShares Global Clean Energy ETF: 337,097 shares worth $5.25M.
- Weil Company added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $3.49M increase.
- Weil Company's biggest Q4 2023 reduction was United Therapeutics, cutting an estimated $6.36M.
- Weil Company fully exited Criteo in Q4 2023, selling an estimated $2.29M.
- Weil Company's ten largest holdings make up 41% of its $228M portfolio in Q4 2023.
- Weil Company opened 16 new positions and closed 13 in Q4 2023.
- Weil Company's portfolio value rose 13% quarter-over-quarter to $228M.
Based on Weil Company's 13F filing for Q4 2023, filed 9 Feb 2024.